Our Experience in the Management of Therapeutic Failures of Fractures of the Proximal End of the Femur (About 35 Cases)

April 8, 2024 updated by: Zied Mansi, Ibn Jazzar Hospital

Osteosyntheses employed in treating fractures at the upper end of the femur play a critical role in facilitating a swift recovery by minimizing immobilization periods and enabling early rehabilitation of the affected joints, thereby promoting a speedy return to normal walking function.

Osteosynthesis alters the mechanical dynamics of the bone segment, which undergoes continual changes during the consolidation and mobilization phases of recovery. Throughout these stages, a range of mechanical complications may arise, posing challenges despite the successful prevention of infections. Non-infectious complications associated with the presence of osteosynthesis materials, especially in weight-bearing areas like the lower limb, remain a concern.

In light of these considerations, surgeons must exercise meticulous care in selecting synthetic materials to mitigate the risk of osteosynthesis failures. In cases where internal fixation fails, the standard recourse often involves converting to total hip arthroplasty (THA).

However, it is essential to note that THA subsequent to complications arising from proximal femur osteosynthesis presents a higher incidence of both intraoperative and postoperative complications compared to the implantation of primary total hip prostheses. Thus, while osteosynthesis remains a valuable intervention for femur fractures, careful attention to material selection and postoperative management is crucial in optimizing patient outcomes and minimizing complications.

Study Overview

Status

Completed

Intervention / Treatment

Detailed Description

The aim was to identify the causes of mechanical failures of osteosynthesis in order to prevent them. Methods: We present the experience of the Department of Surgical Orthopedic Surgery, concerning 35 cases summarized after failure of surgical treatment of a fracture of the proximal end of the femur for a period spreading between January 2015 and December 2021. . The literature already found evidence of the greater complexity of this type of procedure compared to a first-line total hip prosthesis. Accordingly, all this, Prevention is better than cure these stiffnesses through good preoperative planning. Other factors related to the terrain or to untimely loading of the implant are more difficult to control. Whatever the cause, the surgeon remains by the rigor in these indications, the choice of the synthetic material the essential element in the prevention of osteosynthesis failures.

Study Type

Observational

Enrollment (Actual)

35

Contacts and Locations

This section provides the contact details for those conducting the study, and information on where this study is being conducted.

Study Locations

      • Kairouan, Tunisia, 3190
        • IBN jazzar hospital

Participation Criteria

Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.

Eligibility Criteria

Ages Eligible for Study

  • Child
  • Adult
  • Older Adult

Accepts Healthy Volunteers

No

Sampling Method

Non-Probability Sample

Study Population

cases of recurrent fractures of the proximal end of the femur following surgical treatment failure

Description

Inclusion Criteria:

  • • Diagnosis of a fracture of the proximal end of the femur.

    • Subsequent surgical intervention(s) due to failure of initial surgical treatment

Exclusion Criteria:

  • • Those initially treated with total hip arthroplasty.

    • Patients lost to follow-up, not consistently monitored, or untreated after diagnosis of the complication.
    • Cases with incomplete medical records

Study Plan

This section provides details of the study plan, including how the study is designed and what the study is measuring.

How is the study designed?

Design Details

Cohorts and Interventions

Group / Cohort
Intervention / Treatment
cases of recurrent fractures of the proximal end of the femur following surgical treatment failure
Other Names:
  • plate
  • dynamic condylar screw

What is the study measuring?

Primary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Surgical Approach
Time Frame: from enrollment to the of treatment 6 years
type of approach
from enrollment to the of treatment 6 years
Preparation of the Patient
Time Frame: from enrollment to the of treatment 6 years
type of preparation
from enrollment to the of treatment 6 years
Anesthesia
Time Frame: from enrollment to the of treatment 6 years
type of anesthesia
from enrollment to the of treatment 6 years
Type of Surgical Revision
Time Frame: from enrollment to the of treatment 6 years
material implanted for revision
from enrollment to the of treatment 6 years
Types of Prosthesis
Time Frame: from enrollment to the of treatment 6 years
prothesis used
from enrollment to the of treatment 6 years

Secondary Outcome Measures

Outcome Measure
Measure Description
Time Frame
Age Distribution
Time Frame: from enrollment to the end of treatment 6 years
The average age of patients experiencing therapeutic failure after surgical treatment of proximal femur fractures was 66 years, with ages ranging from 28 to 94 years. The age group 50-90 years constituted 68.59% of cases.
from enrollment to the end of treatment 6 years
Distribution by Sex
Time Frame: from enrollment to the end of treatment 6 years
Females represented a slight majority in the study, accounting for 57% (20 women), while males comprised 43% (15 men).
from enrollment to the end of treatment 6 years
Distribution According to Affected Side
Time Frame: from enrollment to the end of treatment 6 years
The right side was affected in 60% (21 cases), while the left side was affected in 40% (14 cases).
from enrollment to the end of treatment 6 years
Distribution According to Circumstances of Trauma
Time Frame: from enrollment to the end of treatment 6 years
Fractures were predominantly due to minimal trauma, with rare occurrences related to road accidents or domestic falls, attributed to bone fragility and muscle atrophy. One case of a pathological fracture was observed in a patient with dislocation of an intermediate hip prosthesis due to ovarian cancer.
from enrollment to the end of treatment 6 years

Collaborators and Investigators

This is where you will find people and organizations involved with this study.

Study record dates

These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.

Study Major Dates

Study Start (Actual)

January 1, 2015

Primary Completion (Actual)

December 1, 2021

Study Completion (Actual)

December 2, 2021

Study Registration Dates

First Submitted

March 28, 2024

First Submitted That Met QC Criteria

April 8, 2024

First Posted (Actual)

April 11, 2024

Study Record Updates

Last Update Posted (Actual)

April 11, 2024

Last Update Submitted That Met QC Criteria

April 8, 2024

Last Verified

April 1, 2024

More Information

Terms related to this study

Plan for Individual participant data (IPD)

Plan to Share Individual Participant Data (IPD)?

NO

IPD Plan Description

use for other resaerchs

Drug and device information, study documents

Studies a U.S. FDA-regulated drug product

No

Studies a U.S. FDA-regulated device product

No

This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.

Clinical Trials on Proximal Femur Fractures

Clinical Trials on total hip arthroplasty

3
Subscribe